Wallén P, Bergsdorf N, Rånby M
Biochim Biophys Acta. 1982 Nov 24;719(2):318-28. doi: 10.1016/0304-4165(82)90105-2.
Porcine tissue plasminogen activator has been purified from delipidized heart tissue by affinity adsorption to fibrin. A crude fraction is prepared from an acid tissue extract by precipitation with ammonium sulphate. The tissue activator of this fraction is isolated by adsorption on fibrin and elution with KSCN. The procedure also includes chromatography on arginine-Sepharose and two gel-filtration steps. The final product has a specific activity of 250 000 IU/mg (+/- 16 000) as compared to an international urokinase reference preparation. The yield calculated from the active ammonium sulphate precipitate is about 28%. An approx. 7 000-fold increase of specific activity is obtained, most of which is achieved in the fibrin step. The native tissue plasminogen activator consists of a single chain molecule with a molecular weight of 64 000 as measured by SDS-polyacrylamide gel electrophoresis. In a previous report, it was claimed that the activator is composed of two disulphide-connected polypeptide chains. These results were due to a preparation artefact, caused by proteolytic activity present in the tissue extracts. The introduction of the protease inhibitor aprotinin and 6-amino-hexanoic acid in the purification procedure has abolished the effect of the protease contaminant, leading to the production of a one-chain activator. Treatment with plasmin transforms the native, one-chain tissue activator into a variant composed of two chains of about equal size (Mr 32 000) connected by disulphide bonding. This modified activator is indistinguishable from the one obtained at insufficient protection against proteolytic enzymes. The cleavage by plasmin causes about an 8-fold increase of amidolytic activity as measured on H-D-Val-Gly-Arg-p-nitroanilide. The fibrinolytic activity as measured by clot lysis in only slightly increased. The physiological significance of the cleavage is discussed.
猪组织纤溶酶原激活剂已通过与纤维蛋白的亲和吸附从脱脂心脏组织中纯化出来。通过用硫酸铵沉淀从酸性组织提取物中制备粗分级分。该分级分的组织激活剂通过吸附在纤维蛋白上并用硫氰酸钾洗脱来分离。该方法还包括在精氨酸 - 琼脂糖上的色谱法和两个凝胶过滤步骤。与国际尿激酶参考制剂相比,最终产物的比活性为250000 IU/mg(±16000)。从活性硫酸铵沉淀物计算的产率约为28%。比活性大约增加了7000倍,其中大部分是在纤维蛋白步骤中实现的。通过SDS - 聚丙烯酰胺凝胶电泳测量,天然组织纤溶酶原激活剂由分子量为64000的单链分子组成。在先前的一份报告中,声称该激活剂由两条通过二硫键连接的多肽链组成。这些结果是由于组织提取物中存在的蛋白水解活性导致的制备假象。在纯化过程中引入蛋白酶抑制剂抑肽酶和6 - 氨基己酸消除了蛋白酶污染物的影响,从而产生了单链激活剂。用纤溶酶处理可将天然的单链组织激活剂转化为由两条大小大致相等(Mr 32000)的链通过二硫键连接而成的变体。这种修饰后的激活剂与在对蛋白水解酶保护不足时获得的激活剂无法区分。纤溶酶的切割导致在H - D - 缬氨酸 - 甘氨酸 - 精氨酸 - 对硝基苯胺上测量的酰胺水解活性增加约8倍。通过凝块溶解测量的纤溶活性仅略有增加。讨论了切割的生理意义。